can doctors still prescribe compounded semaglutide FDA alerts health care providers, compounders and patients of dosing errors associated with injectable products FDA Warns on Certain Forms

Weight loss edge: tirzepatide The clinical evidence is now definitive tirzepatide produces greater average weight loss than semaglutide across trials and real-world data

Significantly higher level of SOD has been observed among chronically ill patients taking antipsychotic drugs than in patients in the first episode

[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Li Y, Zeng X, Lu D, Yin M, Shan M, Gao Y

Read the full story and see the results in Fierce Healthcare: #PBM #PharmacyBenefits #GLP1 RxSense helps client keep GLP-1s on formulary with real-time claims adjudication With real-time claims adjudication, configurable benefit tools, and the flexibility to adapt programs quickly, RxSense helped its client keep GLP-1s on formulary